| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli M Di Nicola, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, ... Blood, The Journal of the American Society of Hematology 99 (10), 3838-3843, 2002 | 4368 | 2002 |
| Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation AM Gianni, M Bregni, AC Stern, S Siena, C Tarella, A Pileri, G Bonadonna The Lancet 334 (8663), 580-585, 1989 | 960 | 1989 |
| Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a … CH Moskowitz, A Nademanee, T Masszi, E Agura, J Holowiecki, MH Abidi, ... The Lancet 385 (9980), 1853-1862, 2015 | 846 | 2015 |
| Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients S Siena, M Bregni, B Brando, N Belli, F Ravagnani, L Gandola, AC Stern, ... | 690 | 1991 |
| Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte … S Siena, M Bregni, B Brando, F Ravagnani, G Bonadonna, AM Gianni | 685 | 1989 |
| High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma AM Gianni, M Bregni, S Siena, C Brambilla, M Di Nicola, F Lombardi, ... New England Journal of Medicine 336 (18), 1290-1298, 1997 | 646 | 1997 |
| ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned S Viviani, PL Zinzani, A Rambaldi, E Brusamolino, A Levis, V Bonfante, ... New England Journal of Medicine 365 (3), 203-212, 2011 | 509 | 2011 |
| Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type A Conconi, G Martinelli, C Thiéblemont, AJM Ferreri, L Devizzi, ... Blood 102 (8), 2741-2745, 2003 | 481 | 2003 |
| Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic … P Corradini, A Dodero, F Zallio, D Caracciolo, M Casini, M Bregni, F Narni, ... Journal of Clinical Oncology 22 (11), 2172-2176, 2004 | 376 | 2004 |
| Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group G Ryan, G Martinelli, M Kuper-Hommel, R Tsang, G Pruneri, K Yuen, ... Annals of Oncology 19 (2), 233-241, 2008 | 327 | 2008 |
| A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies SP Perrine, O Hermine, T Small, F Suarez, R O'Reilly, F Boulad, ... Blood 109 (6), 2571-2578, 2007 | 327 | 2007 |
| Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer M Magni, S Shammah, R Schiro, W Mellado, R Dalla-Favera, AM Gianni | 312 | 1996 |
| Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation P Corradini, C Tarella, F Zallio, A Dodero, M Zanni, P Valagussa, ... Leukemia 20 (9), 1533-1538, 2006 | 309 | 2006 |
| Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion M Magni, M Di Nicola, L Devizzi, P Matteucci, F Lombardi, L Gandola, ... Blood, The Journal of the American Society of Hematology 96 (3), 864-869, 2000 | 306 | 2000 |
| Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. S Siena, M Di Nicola, M Bregni, R Mortarini, A Anichini, L Lombardi, ... Experimental hematology 23 (14), 1463-1471, 1995 | 297 | 1995 |
| Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis … M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti, A Rambaldi, ... Blood, The Journal of the American Society of Hematology 111 (8), 4004-4013, 2008 | 294 | 2008 |
| Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) AM Gianni, M Magni, M Martelli, M Di Nicola, C Carlo-Stella, S Pilotti, ... Blood 102 (2), 749-755, 2003 | 289 | 2003 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 265 | 2021 |
| Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ... haematologica 87 (12), 1258-1264, 2002 | 243 | 2002 |
| Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in … AM Gianni, M Bregni, S Siena, A Orazi, AC Stern, L Gandola, ... Journal of Clinical Oncology 8 (5), 768-778, 1990 | 229 | 1990 |
marco bregniazienda ospedaliera busto arsizio在 aobusto.it 的电子邮件经过验证
